BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

DSM N.V. Announces Multi-Year Collaboration with UMC Utrecht for Feasibility Study of Novel Transcatheter Heart Valves Made with Dyneema Purity® Fibers


2/21/2012 8:10:53 AM

BERKELEY, Calif.--(BUSINESS WIRE)--DSM, a global leader in biomedical materials sciences, and University Medical Center Utrecht, a leading academic hospital with a renowned experimental facility unit for cardiothoracic interventions today announced that they have entered into a collaboration agreement. DSM will contribute its Dyneema Purity® fiber technology to enable UMC Utrecht to develop and evaluate a prototype of a non-biological supportive scaffold for the minimally invasive treatment of valvular and vascular diseases.

The primary objective of this collaboration is to combine UMC Utrecht’s clinical expertise and cardiovascular device testing experience with DSM’s innovative fiber technology and fiber processing expertise. UMC Utrecht chose DSM’s Dyneema Purity® fibers for designing heart valve and blood vessel wound closure devices for their extreme strength, high flex fatigue resistance, low elongation, minimal profile and tear resistant properties.

This collaboration fits with the open innovation agenda that DSM pursues. The end goal of thiscollaboration is to build up know-how and assess the preclinical feasibility of a fiber-based heart valve. Once demonstrated feasibility, DSM and UMC Utrecht will jointly reach out to medical device companies to explore options for further development.

“DSM is pleased to make Dyneema Purity® fibers available to the renowned team at UMC Utrecht. This technology will provide surgeons with a material that has the strength and durability to potentially endure the severe mechanicalconditions that a heart valve leaflet is exposed to. We are dedicated to open innovation and seek opportunities to link our technology to innovative research on an ongoing basis. Through collaborative partnerships we can explore new ideas and create solutions that provide better outcomes for patients,” said Carola Hansen, Business Manager for Dyneema Purity® fiber, DSM Biomedical.

With a team of internationally renowned heart and vascular surgeons, and researchers supervised by Gerard Pasterkamp, M.D., PhD., UMC Utrecht has clinical expertise on the latest developments in heart valve technology as lately applied by Jolanda Kluin, M.D., PhD and less invasive vascular treatments performed by Joost van Herwaarden, M.D., PhD.

“We believe that heart valves with scaffolding made from Dyneema Purity® fibers have the potential to lead to a revolutionary new solution, giving those dealing with heart disease the benefit of a less invasive transcatheter heart valve replacement. Although we are in a very early feasibility stage and prototyping only, we believe Dyneema Purity® fiber is a very interesting material to use as basis for this feasibility study.” said Principal Investigator Paul Gründeman, M.D., Ph.D., Division Heart and Lungs at UMC Utrecht.

“Typically, Dyneema Purity® fiber has great potential in novel approaches to minimal invasive vascular surgical therapies because of its unique properties” said Frans L. Moll M.D., Ph.D., Department of Vascular Surgery at UMC Utrecht.

DSM – Bright Science. Brighter Living.™

Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in life sciences and materials sciences DSM is driving economic prosperity,environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements,personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 22,000 employees deliver annual net sales of about € 9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.

About UMC Utrecht

The University Medical Center of Utrecht (UMC Utrecht) is one of the largest public healthcare institutions in the Netherlands. With almost 11,000 employees, UMC Utrecht is constantly building on the provision of good healthcare services, based on the right people and knowledge. UMC Utrecht is a leading international academic medical center where knowledge of health, illness and care is generated, evaluated, shared and applied for the benefit of patients and society. UMC Utrecht is one of the participating centers in the NFU, the Dutch organization for University Medical Centers. The NFU is the result of a merger of the Netherland’s university hospitals and medical centers.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES